Similar articles for PMID: 29040754

Year	Number of Results
1985	1
1989	1
1990	1
1997	1
1998	1
1999	1
2004	3
2005	1
2006	1
2008	1
2009	1
2010	4
2011	7
2012	4
2013	8
2014	10
2015	16
2016	11
2017	18
2018	8
2019	7
2020	14
2021	7
2022	2

1

Development of unique cytotoxic chimeric antigen receptors based on human scFv targeting B7H6.

Hua CK, Gacerez AT, Sentman CL, Ackerman ME. Hua CK, et al. Protein Eng Des Sel. 2017 Oct 1;30(10):713-721. doi: 10.1093/protein/gzx051. Protein Eng Des Sel. 2017. PMID: 29040754 Free PMC article.

2

Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30.

Butler SE, Brog RA, Chang CH, Sentman CL, Huang YH, Ackerman ME. Butler SE, et al. Cancer Immunol Immunother. 2022 Jan;71(1):165-176. doi: 10.1007/s00262-021-02971-y. Epub 2021 May 27. Cancer Immunol Immunother. 2022. PMID: 34046711

3

Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression.

Gacerez AT, Hua CK, Ackerman ME, Sentman CL. Gacerez AT, et al. Cancer Immunol Immunother. 2018 May;67(5):749-759. doi: 10.1007/s00262-018-2124-1. Epub 2018 Feb 16. Cancer Immunol Immunother. 2018. PMID: 29453518

4

B7H6-derived peptides trigger TNF-α-dependent immunostimulatory activity of lymphocytic NK92-MI cells.

Phillips M, Romeo F, Bitsaktsis C, Sabatino D. Phillips M, et al. Biopolymers. 2016 Sep;106(5):658-72. doi: 10.1002/bip.22879. Biopolymers. 2016. PMID: 27216712

5

B7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines.

Bjørnsen EG, Thiruchelvam-Kyle L, Hoelsbrekken SE, Henden C, Saether PC, Boysen P, Daws MR, Dissen E. Bjørnsen EG, et al. Eur J Immunol. 2019 Jan;49(1):54-65. doi: 10.1002/eji.201847746. Epub 2018 Dec 13. Eur J Immunol. 2019. PMID: 30512185 Free article.

6

Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.

Xu X, Li Y, Gauthier L, Chen Q, Vivier E, Mariuzza RA. Xu X, et al. Acta Crystallogr F Struct Biol Commun. 2015 Jun;71(Pt 6):697-701. doi: 10.1107/S2053230X15006755. Epub 2015 May 20. Acta Crystallogr F Struct Biol Commun. 2015. PMID: 26057798 Free PMC article.

7

B7H6-specific chimeric antigen receptors lead to tumor elimination and host antitumor immunity.

Wu MR, Zhang T, DeMars LR, Sentman CL. Wu MR, et al. Gene Ther. 2015 Aug;22(8):675-84. doi: 10.1038/gt.2015.29. Epub 2015 Apr 1. Gene Ther. 2015. PMID: 25830550 Free PMC article.

8

Characterization of B7H6, an endogenous ligand for the NK cell activating receptor NKp30, reveals the identity of two different soluble isoforms during normal human pregnancy.

Gutierrez-Franco J, Hernandez-Gutierrez R, Bueno-Topete MR, Haramati J, Navarro-Hernandez RE, Escarra-Senmarti M, Vega-Magaña N, Del Toro-Arreola A, Pereira-Suarez AL, Del Toro-Arreola S. Gutierrez-Franco J, et al. Immunobiology. 2018 Jan;223(1):57-63. doi: 10.1016/j.imbio.2017.10.012. Epub 2017 Oct 6. Immunobiology. 2018. PMID: 29055565

9

HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity.

Peipp M, Derer S, Lohse S, Staudinger M, Klausz K, Valerius T, Gramatzki M, Kellner C. Peipp M, et al. Oncotarget. 2015 Oct 13;6(31):32075-88. doi: 10.18632/oncotarget.5135. Oncotarget. 2015. PMID: 26392331 Free PMC article.

10

Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC.

Flajnik MF, Tlapakova T, Criscitiello MF, Krylov V, Ohta Y. Flajnik MF, et al. Immunogenetics. 2012 Aug;64(8):571-90. doi: 10.1007/s00251-012-0616-2. Epub 2012 Apr 11. Immunogenetics. 2012. PMID: 22488247 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed